High Tower Advisors, LLC Soma Logic, Inc. Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.76 - $2.83 $4,400 - $7,075	2,500 Added 3.85%	67,484 $170,000
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $3,112 - $4,979	1,482 Added 2.33%	64,984 $150,000
Q1 2023 May 11, 2023	SELL	$2.13 - $3.6 $912,279 - $1.54 Million	-428,300 Reduced 87.09%	63,502 $161,000
Q4 2022 Feb 08, 2023	SELL	$2.05 - $3.47 $179,032 - $303,045	-87,333 Reduced 15.08%	491,802 $1.23 Million
Q3 2022 Nov 09, 2022	BUY	$0.63 - $5.47 $102,095 - $886,451	162,057 Added 38.86%	579,135 $1.67 Million
Q2 2022 Aug 10, 2022	BUY	$4.27 - $8.26 $738,829 - $1.43 Million	173,028 Added 70.9%	417,078 $1.88 Million
Q1 2022 May 12, 2022	BUY	$7.07 - $11.62 $1.62 Million - $2.67 Million	229,500 Added 1577.32%	244,050 $1.96 Million
Q4 2021 Feb 10, 2022	BUY	$10.49 - $14.28 $152,629 - $207,774	14,550 New	14,550 $170,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.